Advances in Gastroenterology and GI Surgery

Innovative Care for Digestive Disorders from New York’s #1 Hospital.

Our team of physicians and digestive care experts offer procedures, services, and facilities based on the latest medical advances that can be challenging to find elsewhere. One of the most experienced in the country, our program provides comprehensive care and a wide range of treatment options, all in one location.

3D illustration of fatty liver disease and hepatic steatosis

Advancing Understanding and Management of Fatty Liver Disease

Gastroenterologists at NewYork-Presbyterian Hospital continue to characterize the biological mechanisms of non-alcoholic fatty liver disease, define best practices for its management, and pursue research to identify effective treatment options.

Microscopic image of colonic adenocarcinoma with hematoxylin and eosin stain

Lynch Syndrome: Reducing the Risk of Cancer with Genetic Precision

Comprehensive GI Clinical Cancer Genetics programs at NewYork-Presbyterian Hospital are furthering understanding of inherited cancer syndromes such as Lynch syndrome to facilitate early screening and prevent the development of colorectal cancer.

Medical illustration representing sleeve gastrectomy and gastric bypass

Spearheading Advances in Bariatric Surgery

Comprehensive and collaborative bariatric surgery and weight management programs at NewYork-Presbyterian Hospital are providing integrated care by endocrinologists and surgeons, helping patients achieve significant and durable weight loss and improve overall health.

image of Ulcerative Colitis

Tackling Treatment Challenges in IBD

Columbia and Weill Cornell gastroenterologists and GI surgeons are advancing the care of inflammatory bowel disease, including pouch disorders, though new program initiatives and research that span a range of investigations from the laboratory to the clinic to further development of effective therapies.

image of Dr. Kelley Yan

Revealing the Role of Stem Cells in Gut Regeneration

Studies of intestinal stem cells are shedding light on the mechanisms of gut regeneration. A physician-scientist at NewYork-Presbyterian/Columbia has set her sights on applying the discoveries made in her lab to improve tissue healing and treatment for the many diseases that can affect the gut.

image of Dr. John M. Poneros

A New Pancreatitis Program: Comprehensive Care for Progressive Pancreatic Disease

Given our experience and the enormous volume of patients with pancreatic disease that we see here at Columbia, we felt that it was valuable to formalize our treatment of these patients with a full-service program.

image of Dr. Jeffrey W. Milsom

A Long and Winding Road: Scoping Out Uncharted Territory in the Colon

The DiLumen Endolumenal Interventional Platform (EIP) developed at NewYork-Presbyterian/Weill Cornell is paving the way for dramatic changes in the treatment of many intestinal diseases.

image of Dr. Tamas A. Gonda

Pancreatic Cysts: When Is There a Cause for Concern?

The Pancreatic Cyst Surveillance Program at NewYork-Presbyterian/Columbia helps identify patients with pancreatic cysts who are at risk for developing cancer and those who are not.

image of Dr. Carl V. Crawford

Fecal Transplant: An Old Remedy Made New

While the use of fecal material as a medical remedy dates back to the fourth century, usage waned. In recent years, fecal microbiota transplant to control multiple relapses of Clostridium difficile infections is rising.

image of Dr. Daniel E. Freedberg

Proton Pump Inhibitors: The Risk-Benefit Equation

Proton pump inhibitors (PPIs) have become one of the top oral medications in the United States. With the rise of use, clinicians and researchers at NewYork-Presbyterian/Columbia are studying the possibility of adverse effects of these drugs.

Newsletters for Medical Professionals

2022 Issue 2

2022 Issue 1

2021 Issue 3

2021 Issue 2

2021 Issue 1

2020 Issue 1

2019 Issue 2

2019 Issue 1

2018 Issue 2

2018 Issue 1

2017 Issue 2

  • Mobile Health Technology: Tracking Postop Recovery to Improve Outcomes
  • Proton Pump Inhibitors: The Risk-Benefit Equation

2017 Issue 1

  • Motility Disorders: A Comprehensive Management Approach
  • NAFLD Research: Making Progress on Many Fronts

2016 Issue 3

Spring 2016

Fall/Winter 2015

Spring 2015

November/December 2014

June/July 2014

January 2014

October/November 2013

February 2013

January 2013